LifeScience
Complements Existing Specialty Diagnostics Offering with Established Technologies Delivering Strong Clinical Value for Patients in a Rapidly Growing...
November 01, 2022 | News
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization for biologics, vaccines, and advanced therapies toda...
October 28, 2022 | News
Aragen Life Sciences (Aragen), a leading Contract Research, Development, and Manufacturing Organization (CRDMO), with eight facilities across In...
October 28, 2022 | News
Company’s scientific leadership will be highlighted in 39 abstracts presented across its multiple sclerosis (MS) portfolio Data on investigational...
October 26, 2022 | News
These R&D environments, focused on providing analytical expertise for both small and large molecules, will advance scientific knowledge on the developm...
October 26, 2022 | News
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today presents interim pre-c...
October 25, 2022 | News
Sartorius entered a research partnership with The BASE Facility at The University of Queensland (UQ) to improve the manufacturing process of nucleic a...
October 24, 2022 | News
Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ DynaCellect™ Magnetic Separation ...
October 21, 2022 | News
Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the...
October 13, 2022 | News
“Big 3” expected to generate around 80% of sales growth and > 50% of total sales in 2025 Strategic and targeted investments for annu...
October 11, 2022 | News
An Immunity research study has found that the previously identified disease associated microglia (DAM) population detected in murine Alzheimer’s dise...
October 11, 2022 | News
Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...
September 28, 2022 | News
NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...
September 27, 2022 | News
JB Pharma is sitting pretty, ranked at a healthy 23 among the Indian Pharmaceutical players and underlining its meteoric rise with an outstanding growth ra...
September 22, 2022 | News
Most Read
Bio Jobs
News
Editor Picks